PLUR:NASDAQ
Pluri Inc
၂.၁၆ US$
arrow_upward
+၁.၈၉%(+၀.၀၄၀) 1D
၂.၁၈ US$
arrow_upward
+၀.၉၃% (+၀.၀၂၀)todayPre-market
Closed: ဇူ ၆, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
၂.၁၅ US$
High
၂.၃၉ US$
Low
၂.၁၃ US$
Mkt. cap
၂.၃၃ ကုဋေ
Avg. vol.
၁.၂၅ သောင်း
Volume
၁.၁၁ ထောင်
52-wk high
၅.၈၉ US$
52-wk low
၁.၉၉ US$
EPS
-၂.၈၉ US$
Beta
၀.၆၄
Shares outstanding
၁.၀၈ ကုဋေ
No. of employees
၁၃၅
Open
၂.၁၅ US$
High
၂.၃၉ US$
Low
၂.၁၃ US$
Mkt. cap
၂.၃၃ ကုဋေ
Avg. vol.
၁.၂၅ သောင်း
Volume
၁.၁၁ ထောင်
52-wk high
၅.၈၉ US$
52-wk low
၁.၉၉ US$
EPS
-၂.၈၉ US$
Beta
၀.၆၄
Shares outstanding
၁.၀၈ ကုဋေ
No. of employees
၁၃၅
News stories
From sources across the web
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၄ ရက်
Pluri Inc. Q2 2026 Earnings: Wider-than-Expected Loss Drives Stock Decline - Slow Growth Warning
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees၁၃၅
Founded၂၀၀၁ မေ ၁၁
Headquartersဟိုင်ဖ, Haifa District, အစ္စရေး
Sector-
Websitepluri-biotech.com
AI content may include mistakes. Learn more